ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag evolution antibiotic resistance infectious disease

Antibiotics in the Animals We Eat
Bonnie M. Marshall and Stuart B. Levy | Apr 1, 2012 | 3 min read
Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.
Doctors’ Advice to Finish Antibiotics Overlooks Resistance
Abby Olena, PhD | Aug 11, 2017 | 4 min read
There is little evidence that full treatment durations discourage the development of drug-resistant bacteria.
Researchers use bacterial whole genome sequencing to compare the phylogenetic relationship between environmental and clinical samples.
Aquatic Bacteria Reveal a Common Genetic Link to a Deadly Human Pathogen
Iris Kulbatski, PhD | Mar 7, 2022 | 5 min read
Researchers use genetic clues to track the spread of antibiotic resistant bacteria from the environment to patients.
An Eclectic Look at Infectious Diseases
Ricki Lewis | Aug 20, 2000 | 7 min read
Graphic: Cathleen Heard A week after the controversial XIII International AIDS Conference in Durban, South Africa, a much smaller gathering in Atlanta took a broader view of the current emergence and reemergence of many infectious diseases. The International Conference on Emerging Infectious Diseases 2000, held July 16-19, attracted more than 2,000 attendees representing 35 nations. The Centers for Disease Control and Prevention (CDC), the American Society for Microbiology, the Council of State
antibiotics antibiotics resistance persister bacteria bacteriophage
Opinion: We Need More than New Antibiotics to Fight Resistance
Neil S. Greenspan and Arturo Casadevall | Nov 1, 2019 | 3 min read
Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs.
Companies Seeking Solutions To Emerging Drug Resistance
Stephen Hoffert | Apr 12, 1998 | 10 min read
PHASE III NEARS: Cubist Pharmaceuticals has a promising antibiotic--daptomycin--that the company hopes to have in Phase III clinical trials in late 1998 or early 1999. Bacteria are back. Following the discovery and introduction into medicine of penicillin in 1941, intense research in microbiology produced a potent armament of antibiotics that all but eliminated a variety of infectious diseases. With this success, many large pharmaceutical companies scaled back research and development of new
A Y-shaped pink, blue, and light green antibody is in focus on a background of blurred pink and purple color, with other antibodies out of focus in the background.
Phage Display: Finding the One in a Million
Shelby Bradford, PhD | Dec 4, 2023 | 10+ min read
A combinatorial approach enabled high-throughput screening of protein libraries for desired target binding.
Giving Antibiotic Cycling Another Shot
Tracy Vence | Sep 25, 2013 | 3 min read
Switching up the drugs used to treat bacterial infections could help clinicians battle both illness and resistance at the same time.
AIDS Pandemic Provokes Alarming Reassessments Of Infectious Disease
Joshua Lederberg | Jul 11, 1993 | 5 min read
In 1900, infectious disease was the leading cause of mortality in the United States, accounting for at least 37 percent of deaths. By 1950, this had been mitigated to 6.8 percent and, by 1989, to 2.8 percent, with corresponding improvements in life expectancy. These numbers, of course, must be taken with a grain of salt, given the eventual preemptive role of infection in chronic illness, and many disorders whose infectious etiology is still to be recognized. Further, the relative importance
New Antibiotic from Soil Bacteria
Anna Azvolinsky | Jan 7, 2015 | 3 min read
Researchers have isolated a new kind of antibiotic from a previously unknown and uncultured bacterial genus.  

Run a Search

ADVERTISEMENT